Interspecies Scaling of Bosentan, A New Endothelin Receptor Antagonist and Integration of in Vitro Data into Allometric Scaling

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pharmaceutical Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1016037519116PMID 8668687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man.

  2009cited by this paper
• A new extrapolation method from animals to man: application to a metabolized compound, mofarotene.

  1995cited by this paper
• Can Allometric Interspecies Scaling be Used to Predict Human Kinetics?

  1994cited by this paper
• Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.

  1994cited by this paper
• Predicting the hepatic clearance of xenobiotics in humans from in vitro data

  1994cited by this paper
• Interspecies scaling in pharmacokinetics

  1991cited by this paper
• Interspecies pharmacokinetic scaling, biological design and neoteny

  1990cited by this paper
• Comparative drug metabolism of diazepam in hepatocytes isolated from man, rat, monkey and dog.

  1989cited by this paper
• Man versus beast: pharmacokinetic scaling in mammals.

  1986cited by this paper
• Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted.

  1985cited by this paper
• Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species

  1984cited by this paper
• Prediction of the disposition ofβ-lactam antibiotics in humans from pharmacokinetic parameters in animals

  1984cited by this paper
• Drug metabolism in human liver in vitro: Establishment of a human liver bank

  1980cited by this paper
• Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.

  1977cited by this paper
• Preparation of isolated rat liver cells.

  1976cited by this paper

• Methods for assessing the bioaccumulation of hydrocarbons and related substances in terrestrial organisms: A critical review

  2023cites this paper
• Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin‐Containing Monooxygenase 3 Maturational Changes Over Time

  2018cites this paper
• Design and Conduct Considerations for First‐in‐Human Trials

  2018cites this paper
• The effects of aging on hepatic microsomal scaling factor and hepatocellularity number in the horse

  2018cites this paper
• Pharmacokinetics and allometric scaling of antimalarial drugs

  2015cites this paper
• Evaluation of the Allometric Exponents in Prediction of Human Drug Clearance

  2014cites this paper
• Pharmacokinetics.

  2014cites this paper
• Application of Hybrid Approach Based on Empirical and Physiological Concept for Predicting Pharmacokinetics in Humans—Usefulness of Exponent on Prospective Evaluation of Predictability

  2013cites this paper
• Microsoft Word-83629875-file00.docx

  2012cites this paper
• Use of Mechanistic Modeling to Assess Interindividual Variability and Interspecies Differences in Active Uptake in Human and Rat Hepatocytes

  2012cites this paper
• Applications of Human Pharmacokinetic Prediction in First-in-Human Dose Estimation

  2012cites this paper
• Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data

  2012cites this paper
• Risk Assessment in Extrapolation of Pharmacokinetics from Preclinical Data to Humans

  2010cites this paper
• Species scaling and extrapolation.

  2008cites this paper
• Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species

  2007cites this paper
• In Silico Prediction of Oral Bioavailability

  2007cites this paper
• Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance

  2007cites this paper
• A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry.

  2006cites this paper
• ALLOMETRIC SCALING FOR PREDICTING HUMAN DRUG CLEARANCE

  2005cites this paper
• ACCURACY OF ALLOMETRICALLY PREDICTED PHARMACOKINETIC PARAMETERS IN HUMANS: ROLE OF SPECIES SELECTION

  2005cites this paper
• A NOVEL MODEL FOR PREDICTION OF HUMAN DRUG CLEARANCE BY ALLOMETRIC SCALING

  2005cites this paper
• Comparison of clearance predictions using primary cultures and suspensions of human hepatocytes

  2005cites this paper
• Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations.

  2004cites this paper
• Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans.

  2003cites this paper
• Prediction of human pharmacokinetics based on preclinical in vitro and in vivo data.

  2002cites this paper
• Mixed-effects modeling of the interspecies pharmacokinetic scaling of oxytetracycline.

  2002cites this paper
• Prediction of Hepatic Metabolic Clearance

  2001cites this paper
• Pharmacokinetics and its role in small molecule drug discovery research

  2001cites this paper
• In vitro-in vivo correlation of the pharmacokinetics of vinpocetine.

  2001cites this paper
• Pharmacokinetics and interspecies scaling of a novel VEGF receptor inhibitor, SU5416

  2001cites this paper
• The importance of hepatocytes in drug metabolism studies: an industrial perspective

  2000cites this paper
• A COMMENTARY ON THE USE OF HEPATOCYTES IN DRUG METABOLISM STUDIES DURING DRUG DISCOVERY AND DEVELOPMENT*

  2000cites this paper
• Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro-In Vivo Correlations

  1999cites this paper
• Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humans.

  1999cites this paper
• Interspecies Pharmacokinetic Comparisons and Allometric Scaling of Napsagatran, a Low Molecular Weight Thrombin Inhibitor

  1999cites this paper
• Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man.

  1999cites this paper
• Animal pharmacokinetics and interspecies scaling of Ro 25-6833 and related (lactamylvinyl)cephalosporins.

  1998cites this paper
• Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.

  1997cites this paper
• Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs.

  1997cites this paper
• The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.

  1997cites this paper
• Disposition of the selective alpha1A-adrenoceptor antagonist tamsulosin in humans: comparison with data from interspecies scaling.

  1997cites this paper
• Interspecies scaling of tolcapone, a new inhibitor of catechol-O-methyltransferase (COMT). Use of in vitro data from hepatocytes to predict metabolic clearance in animals and humans.

  1996cites this paper